France vs IBRD only: Cause of death, by non-communicable diseases, ages 5-14, male
France
63.0%
in 2021
IBRD only
27.4%
in 2021
France rank
22nd
IBRD only rank
25th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- France
- IBRD only
How they compare
France currently reports 63.0% against 27.4% in IBRD only, a difference of 35.6%.
That makes France's figure about 2.3 times IBRD only's.
Across all 6 years both countries report, France has been ahead every year.
France ranks 22nd and IBRD only ranks 25th of 185 countries.
France has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | France | IBRD only | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.6% | 20.6% | 27.0% | France |
| 2010s | 65.7% | 25.6% | 40.1% | France |
| 2020s | 61.2% | 28.0% | 33.3% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, France or IBRD only?
- France, at 63.0% against 27.4% in IBRD only as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between France and IBRD only?
- 35.6%, with France ahead.
- How many years of comparable data are there for France and IBRD only?
- 6 years are reported by both, from 2000 to 2021.
- How do France and IBRD only rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- France ranks 22nd and IBRD only ranks 25th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.